U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
180181180181Comparison of Immunosuppression Protocols After LTx in ChildrenCompletedNo Results AvailableLiver TransplantationDrug: tacrolimus, steroids, mycophenolate mofetilhttps://ClinicalTrials.gov/show/NCT00195988
180182180182Heart Rate Variability in Children With a Functional Gastrointestinal DisorderCompletedNo Results AvailableAbdominal Painhttps://ClinicalTrials.gov/show/NCT00195975
180183180183Risk Factors of Breastfeeding StudyCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00195962
180184180184Laparoscopic Versus Open Pyloromyotomy for Infants With Idiopathic Hypertrophic Pyloric StenosisCompletedNo Results AvailableHypertrophic Pyloric StenosisProcedure: Laparoscopic pyloromyotomyhttps://ClinicalTrials.gov/show/NCT00195949
180185180185Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic RicketsRecruitingNo Results AvailableHypophosphatemic Rickets, X-Linked DominantDrug: Cinacalcethttps://ClinicalTrials.gov/show/NCT00195936
180186180186Prospective Randomized Evaluation of Antibiotic Regimen Following Appendectomy for Perforated AppendicitisCompletedNo Results AvailablePerforated AppendicitisDrug: Ampicillin, gentamicin, clindamycin, flagyl, ceftazidimehttps://ClinicalTrials.gov/show/NCT00195923
180187180187Safety and Efficacy Study of Hydromorphone and MorphineActive, not recruitingNo Results AvailablePainDrug: Morphine and Hydromorphonehttps://ClinicalTrials.gov/show/NCT00195910
180188180188Early Assessment of Anthracycline-Induced Cardiotoxicity (CARDIOTOX)Not yet recruitingNo Results AvailableLymphoma|Heart Failure, Congestivehttps://ClinicalTrials.gov/show/NCT00195897
180189180189Diabetes Aerobic and Resistance Exercise (DARE) StudyCompletedNo Results AvailableDiabetes Mellitus, Type 2|Diabetes MellitusBehavioral: Aerobic and Resistance Exercisehttps://ClinicalTrials.gov/show/NCT00195884
180190180190Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic LymphomaActive, not recruitingNo Results AvailableLymphoblastic LymphomaDrug: Prednisone, vincristine, daunorubicin , cyclophosphamide , L.-asparaginase, cytosine-arabinoside, methotrexate, etoposide|Procedure: hematopoietic stem cell allografthttps://ClinicalTrials.gov/show/NCT00195871
180191180191Healthy Eating Aerobic and Resistance Training in Youth (HEARTY) TrialCompletedNo Results AvailableObesityBehavioral: aerobic and resistance exercisehttps://ClinicalTrials.gov/show/NCT00195858
180192180192A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar DisorderActive, not recruitingNo Results AvailableBipolar DisorderDrug: Galantaminehttps://ClinicalTrials.gov/show/NCT00195845
180193180193Safety and Efficacy of Adalimumab in Patients With Active Ankylosing SpondylitisCompletedHas ResultsAnkylosing SpondylitisBiological: adalimumab (D2E7)|Biological: placebohttps://ClinicalTrials.gov/show/NCT00195819
180194180194Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With MigraineCompletedNo Results AvailableMigraineDrug: divalproex sodiumhttps://ClinicalTrials.gov/show/NCT00195806
180195180195A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to AtorvastatinCompletedNo Results AvailableHyperlipidemiaDrug: fenofibrate|Drug: ezetimibe|Drug: atorvastatinhttps://ClinicalTrials.gov/show/NCT00195793
180196180196A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and AdolescentsCompletedNo Results AvailableBipolar I DisorderDrug: Divalproex Sodium (Depakote ER)https://ClinicalTrials.gov/show/NCT00195780
180197180197Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and AdolescentsCompletedNo Results AvailableBipolar I Disorder, Manic or MixedDrug: divalproex sodiumhttps://ClinicalTrials.gov/show/NCT00195767
180198180198A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.CompletedNo Results AvailableMigrainesDrug: divalproex sodiumhttps://ClinicalTrials.gov/show/NCT00195754
180199180199The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in AdolescentsCompletedNo Results AvailableMigraineDrug: divalproex sodiumhttps://ClinicalTrials.gov/show/NCT00195741
180200180200Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant PainCompletedNo Results AvailableModerate to Severe Chronic, Non-malignant PainDrug: Hydrocodone/Acetaminophen on Extended Releasehttps://ClinicalTrials.gov/show/NCT00195728
180201180201Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's DiseaseCompletedHas ResultsCrohn's DiseaseBiological: Adalimumabhttps://ClinicalTrials.gov/show/NCT00195715
180202180202Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.CompletedHas ResultsRheumatoid ArthritisBiological: Adalimumab|Biological: Adalimumab|Drug: Placebo|Biological: Adalimumab|Biological: Adalimumab|Biological: Adalimumabhttps://ClinicalTrials.gov/show/NCT00195702
180203180203Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic ArthritisCompletedNo Results AvailablePsoriatic ArthritisBiological: Human anti-TNF monoclonal antibody/adalimumabhttps://ClinicalTrials.gov/show/NCT00195689
180204180204Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedHas ResultsPsoriasisDrug: adalimumabhttps://ClinicalTrials.gov/show/NCT00195676
180205180205Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid ArthritisCompletedHas ResultsEarly Rheumatoid ArthritisBiological: Adalimumab|Drug: Methotrexate|Biological: Adalimumab placebo|Drug: Methotrexate placebohttps://ClinicalTrials.gov/show/NCT00195663
180206180206Long Term Open Label Continuation StudyCompletedHas ResultsRheumatoid ArthritisBiological: Adalimumabhttps://ClinicalTrials.gov/show/NCT00195650
180207180207Intravenous Immune Globulin to Treat Hereditary Inclusion Body MyopathyCompletedNo Results AvailableHereditary Inclusion Body MyopathyDrug: Immune Globulinhttps://ClinicalTrials.gov/show/NCT00195637
180208180208Alemtuzumab to Treat Severe Aplastic AnemiaActive, not recruitingNo Results AvailableRelapsed or Refractory Severe Aplastic Anemia|Severe Aplastic AnemiaDrug: Alemtuzumab (Campath )https://ClinicalTrials.gov/show/NCT00195624
180209180209Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis MediaCompletedNo Results AvailableOtitis Media|Otitis Media With Effusion|Pneumococcal InfectionsDrug: Prevenarhttps://ClinicalTrials.gov/show/NCT00195611
180210180210Study Comparing Venlafaxine vs. Paroxetine in Panic DisorderCompletedNo Results AvailablePanic DisordersDrug: VENLAFAXINE|Drug: Paroxetinehttps://ClinicalTrials.gov/show/NCT00195598

* Görseller ve İçerik tekif hakkına sahip olabilir